SAN DIEGO--(BUSINESS WIRE)--June 26, 2006--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH - News) announced today that it has been informed by the Department of Health and Human Services (HHS), in a letter dated June 23, 2006, that Hollis-Eden "is within the competitive range for discussion and further evaluation" with respect to Hollis-Eden's response to HHS' Request for Proposal No. DHHS-ORDC-DDA-05-12 entitled "Medical Countermeasures to Mitigate or Treat Neutropenia Alone or in Combination with Co-Morbidities Associated with Acute Radiation Syndrome (ARS)." This formally begins the negotiation process for a potential procurement. HHS indicated in their letter that the new estimated date of award is September 15, 2006.
